Cargando…
Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study
BACKGROUND: Before the widespread use of primary percutaneous coronary intervention (PCI) and glycoprotein IIb/IIIa inhibitors (GP IIb/IIIa) left ventricular (LV) thrombus formation had been reported to complicate up to 20% of acute myocardial infarctions (AMI). The incidence of LV thrombus formatio...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458359/ https://www.ncbi.nlm.nih.gov/pubmed/16600036 http://dx.doi.org/10.1186/1476-7120-4-20 |
_version_ | 1782127437593706496 |
---|---|
author | Rehan, Arshad Kanwar, Manpreet Rosman, Howard Ahmed, Sujood Ali, Arshad Gardin, Julius Cohen, Gerald |
author_facet | Rehan, Arshad Kanwar, Manpreet Rosman, Howard Ahmed, Sujood Ali, Arshad Gardin, Julius Cohen, Gerald |
author_sort | Rehan, Arshad |
collection | PubMed |
description | BACKGROUND: Before the widespread use of primary percutaneous coronary intervention (PCI) and glycoprotein IIb/IIIa inhibitors (GP IIb/IIIa) left ventricular (LV) thrombus formation had been reported to complicate up to 20% of acute myocardial infarctions (AMI). The incidence of LV thrombus formation with these treatment modalities is not well known. METHODS: 92 consecutive patients with ST-elevation AMI treated with PCI and GP IIb/IIIa inhibitors underwent 2-D echocardiograms, with and without echo contrast agent, within 24–72 hours. RESULTS: Only 4/92 (4.3%) had an LV thrombus, representing a significantly lower incidence than that reported in the pre-PCI era. Use of contrast agents did not improve detection of LV thrombi in our study. CONCLUSION: The incidence of LV thrombus formation after acute MI, in the current era of rapid reperfusion, is lower than what has been historically reported. |
format | Text |
id | pubmed-1458359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-14583592006-05-06 Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study Rehan, Arshad Kanwar, Manpreet Rosman, Howard Ahmed, Sujood Ali, Arshad Gardin, Julius Cohen, Gerald Cardiovasc Ultrasound Research BACKGROUND: Before the widespread use of primary percutaneous coronary intervention (PCI) and glycoprotein IIb/IIIa inhibitors (GP IIb/IIIa) left ventricular (LV) thrombus formation had been reported to complicate up to 20% of acute myocardial infarctions (AMI). The incidence of LV thrombus formation with these treatment modalities is not well known. METHODS: 92 consecutive patients with ST-elevation AMI treated with PCI and GP IIb/IIIa inhibitors underwent 2-D echocardiograms, with and without echo contrast agent, within 24–72 hours. RESULTS: Only 4/92 (4.3%) had an LV thrombus, representing a significantly lower incidence than that reported in the pre-PCI era. Use of contrast agents did not improve detection of LV thrombi in our study. CONCLUSION: The incidence of LV thrombus formation after acute MI, in the current era of rapid reperfusion, is lower than what has been historically reported. BioMed Central 2006-04-06 /pmc/articles/PMC1458359/ /pubmed/16600036 http://dx.doi.org/10.1186/1476-7120-4-20 Text en Copyright © 2006 Rehan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Rehan, Arshad Kanwar, Manpreet Rosman, Howard Ahmed, Sujood Ali, Arshad Gardin, Julius Cohen, Gerald Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study |
title | Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study |
title_full | Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study |
title_fullStr | Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study |
title_full_unstemmed | Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study |
title_short | Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study |
title_sort | incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein iib/iiia inhibitors. a prospective observational study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458359/ https://www.ncbi.nlm.nih.gov/pubmed/16600036 http://dx.doi.org/10.1186/1476-7120-4-20 |
work_keys_str_mv | AT rehanarshad incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy AT kanwarmanpreet incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy AT rosmanhoward incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy AT ahmedsujood incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy AT aliarshad incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy AT gardinjulius incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy AT cohengerald incidenceofpostmyocardialinfarctionleftventricularthrombusformationintheeraofprimarypercutaneousinterventionandglycoproteiniibiiiainhibitorsaprospectiveobservationalstudy |